Bayer Schering’s contraceptive patch enters phase III
May 5, 2009Research and Development, Sales and Marketing Bayer, sexual health
Bayer Schering is to start phase III trials of its new contraceptive patch and anticipates submitting the product for regulatory …
EDQM takes issue with more Chinese APIs
May 5, 2009Manufacturing and Production Asia, China
The European Directorate on the Quality of Medicines has suspended the certificates of suitability (CEPs) of four active pharmaceutical ingredients …
Coast first casualty in US overhaul of IRB system
May 5, 2009Research and Development FDA, US
A US company offering institutional review board services to sponsors of clinical trials has been forced to close its doors …
Pfizer dips in first quarter
May 1, 2009Sales and Marketing Pfizer
Pfizer saw its performance dip in the first quarter of 2009, with revenue down 8% year-on-year. The company, which is …
Biotech partnering in the credit crunch
May 1, 2009Research and Development biotech, partnering, pharma
Action Pharma’s Torben Jung Laursen explores the new challenges facing pharma-biotech partnering as a result of the economic downturn.In today’s …
BMS turns in solid first quarter results
May 1, 2009Sales and Marketing BMS
Bristol-Myers Squibb turned in respectable figures for the first quarter of 2008, with net income up 5% to $921 million. …
UK’s branded pharma sales predicted to decline
May 1, 2009Sales and Marketing NHS
As part of the UK government's drive to save £2.3 billion in the NHS during 2010-11, £550m will be cut …
Avastin fails in colon cancer study
April 30, 2009Research and Development Cancer, Roche
Roche's blockbuster Avastin has failed to show success in treating early-stage colon cancer. A phase III trial found Avastin (bevacizumab) …
Sanofi makes cuts to phase III pipeline
April 30, 2009Research and Development Sanofi-Aventis
Sanofi-Aventis has suspended development of four late-stage drugs and ten other projects following an R&D review. The decision was announced …
NICE could ease QALY to boost innovation
April 30, 2009Research and Development NICE
NICE could be set to dramatically change its cost-effectiveness measure and help boost innovation in the UK, according to Sir …
Minister thanks pharma for help in swine flu fight
April 30, 2009Research and Development h1n1
Health secretary Alan Johnson kept an appointment to address the ABPI's annual conference yesterday despite the spread of swine flu …
Developing health, developing profits
April 30, 2009Research and Development, Sales and Marketing Pfizer, healthcare, working poor
Pfizer's Dr Ponni Subbiah is at the forefront of a revolution in the way the pharma industry views its business, …
Nexavar fails in melanoma study
April 30, 2009Research and Development Bayer, Cancer, Nexavar
Onyx Pharmaceuticals and its development partner Bayer have stopped a phase II trial of Nexavar in patients with late-stage melanoma, …
Recession hits Merck KGaA profits
April 29, 2009Sales and Marketing Merck Serono
Merck KGaA saw its profits fell through the floor for the first quarter this year due to a combination of …
Microdosing shows its mettle in cancer study
April 29, 2009Research and Development Microdosing
Newly-released data has added additional weight to the evidence for microdosing studies as a means to predict whether or not …
UK scientists to examine swine flu
April 29, 2009Research and Development h1n1
UK scientists will examine new samples of swine influenza as part of the global race to develop a vaccine against …
GSK pledges help in flu outbreak
April 28, 2009Research and Development GSK, h1n1
GlaxoSmithKline has pledged to closely monitor the swine flu outbreak that began in Mexico, and assist in access to treatment …
IDIS and Ogilvy to promote named patient programme
April 28, 2009Medical Communications, Sales and Marketing IDIS, Ogilvy
Specialist medicines supplies company IDIS has hired a leading PR agency to help promote its business across Europe. Ogilvy Healthworld …
The changing face of Continuing Medical Education in Europe
April 28, 2009Medical Communications, Sales and Marketing Continuing medical education, Europe
There is currently no unified approach to delivering Continuing Medical Education (CME) in Europe, and the provision of CME is …
Patheon takeover stymied by regulators
April 28, 2009Manufacturing and Production Patheon
A hostile takeover bid for Canadian contract manufacturer Patheon by private equity firm JLL Partners has been blocked by the …
Latest content
